Načítá se...
Do cross-reactive antibodies cause neuropathology in COVID-19?
Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can cross-react with mammalian proteins. Focusing on neurological symptoms, we discuss whether these cross-reactive antibodies co...
Uloženo v:
| Vydáno v: | Nat Rev Immunol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537977/ https://ncbi.nlm.nih.gov/pubmed/33024283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-020-00458-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|